Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
OBIO · NASDAQ · Surgical & Medical Instruments & Apparatus
Orchestra Biomed Holdings (OBIO) · oqro.io/stocks/OBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$7.25+1.10 (+17.89%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
48 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
5 insiders in a week, a first since 2020Traded Nov 9 · filed 3 days later
Since the trade +27.2% · S&P 500 +0.2% · to Nov 13
A major shareholder of Orchestra Biomed paid $6M out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 19 months.
Insider buying
5 insiders in a week, a first since 2020Traded Nov 9 · filed the same day
Since the trade +27.2% · S&P 500 +0.2% · to Nov 13
An Orchestra Biomed director paid $100K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in over a year.
Insider buying
5 insiders in a week, a first since 2020Traded Nov 9 · filed the same day
Since the trade +27.2% · S&P 500 +0.2% · to Nov 13
An Orchestra Biomed director paid $100K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 6 months.
Insider buying
5 insiders in a week, a first since 2020Traded Nov 9 · filed the same day
Since the trade +27.2% · S&P 500 +0.2% · to Nov 13
The CFO of Orchestra Biomed paid $5K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 15 months.
Insider buying
5 insiders in a week, a first since 2020Traded Nov 9 · filed the same day
Since the trade +27.2% · S&P 500 +0.2% · to Nov 13
An Orchestra Biomed director paid $25K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month.
Darren Sherman (See Remarks) sold ~$86K of Orchestra Biomed Holdings
Planned saleSherman Darren (Officer) plans to sell ~$89K of Orchestra Biomed Holdings
Planned, from payDarren Sherman (See Remarks) sold ~$95K of Orchestra Biomed Holdings
Planned saleInsider buying
Traded Sep 3 · filed 5 days later
Since the trade +53.0% · S&P 500 −2.4% · to Nov 13
An Orchestra Biomed director paid $48K out of pocket for Orchestra Biomed shares. 1 other person at Orchestra Biomed bought some too, in the same month.
Darren Sherman (See Remarks) sold ~$74K of Orchestra Biomed Holdings
Planned saleInsider buying
Traded Aug 26 · filed 2 days later
Since the trade +37.8% · S&P 500 −1.5% · to Nov 13
An Orchestra Biomed director paid $11K out of pocket for Orchestra Biomed shares. 1 other person at Orchestra Biomed bought some too, in the same month.
Darren Sherman (See Remarks) sold ~$61K of Orchestra Biomed Holdings
Planned saleDarren Sherman (See Remarks) sold ~$64K of Orchestra Biomed Holdings
Planned saleInsider buying
Traded Jun 1 · filed 1 day later
Since the trade +89.3% · S&P 500 −0.6% · to Nov 13
An Orchestra Biomed director paid $19K out of pocket for Orchestra Biomed shares. 2 other people at Orchestra Biomed bought some too, in the same month.
Darren Sherman (See Remarks) sold ~$58K of Orchestra Biomed Holdings
Planned saleTraded May 15 – May 18, 2026 · largest single transaction ~$35K
May 18, 2026~$2.5K · 665 sh @ $3.75
DetailsOfficial recordInsider buying
3 insiders in a week, 3rd time since 2020Traded May 15 · filed 4 days later
Since the trade +94.9% · S&P 500 +2.1% · to Nov 13
An Orchestra Biomed director paid $19K out of pocket for Orchestra Biomed shares. 2 other people at Orchestra Biomed bought some too, in the same month.
Insider buying
Traded May 14 · filed 4 days later
Since the trade +76.4% · S&P 500 +0.8% · to Nov 13
An Orchestra Biomed director paid $83K out of pocket for Orchestra Biomed shares. 2 other people at Orchestra Biomed bought some too, in the same month. Shares held went up 28% with this purchase.
Rtw Investments (LP, 10% owner) sold ~$132 of Orchestra Biomed Holdings
Automatic saleInsider buying
Traded Mar 13 · filed 3 days later
Since the trade +72.6% · S&P 500 +13.9% · to Nov 13
An Orchestra Biomed director paid $43K out of pocket for Orchestra Biomed shares.
Insider buying
Traded Nov 14, 2025 · filed 3 days later
Since the trade +84.0% · S&P 500 +12.3% · to Nov 13
An Orchestra Biomed director paid $20K out of pocket for Orchestra Biomed shares.
Insider buying
Their first buy on recordTraded Sep 19, 2025 · filed the same day
Since the trade +197.1% · S&P 500 +13.7% · to Nov 13
An Orchestra Biomed director paid $2.5K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month.
Insider buying
Traded Aug 25, 2025 · filed the same day
Since the trade +178.8% · S&P 500 +17.4% · to Nov 13
An Orchestra Biomed director paid $15K out of pocket for Orchestra Biomed shares. 5 other people at Orchestra Biomed bought some too, in the same month. Shares held went up 9% with this purchase.
Insider buying
Traded Aug 25, 2025 · filed the same day
Since the trade +178.8% · S&P 500 +17.4% · to Nov 13
The CFO of Orchestra Biomed paid $5.1K out of pocket for Orchestra Biomed shares. 5 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 8 months.
Insider buying
Traded Aug 21, 2025 · filed 4 days later
Since the trade +191.2% · S&P 500 +18.7% · to Nov 13
An Orchestra Biomed director paid $15K out of pocket for Orchestra Biomed shares. 5 other people at Orchestra Biomed bought some too, in the same month.
Insider buying
Traded Aug 25, 2025 · filed the same day
Since the trade +178.8% · S&P 500 +17.4% · to Nov 13
An Orchestra Biomed director paid $7.9K out of pocket for Orchestra Biomed shares. 5 other people at Orchestra Biomed bought some too, in the same month.
Insider buying
Traded Aug 1, 2025 · filed 4 days later
Since the trade +197.1% · S&P 500 +21.3% · to Nov 13
A major shareholder of Orchestra Biomed paid $1.93M out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. Shares held went up 15% with this purchase.
Insider buying
Traded Aug 4, 2025 · filed the same day
Since the trade +170.5% · S&P 500 +19.5% · to Nov 13
An Orchestra Biomed director paid $55K out of pocket for Orchestra Biomed shares. 4 other people at Orchestra Biomed bought some too, in the same month. It was the first purchase in 8 months.
Eric S Fain (Director) sold ~$8.2K of Orchestra Biomed Holdings
Automatic saleTraded Apr 29 – Apr 30, 2025 · largest single transaction ~$149K
Apr 30, 2025~$149K · 50K sh @ $2.99
DetailsOfficial recordInsider buying
Traded Dec 23, 2024 · filed 3 days later
Since the trade +54.6% · S&P 500 +26.9% · to Nov 13
An Orchestra Biomed director paid $19K out of pocket for Orchestra Biomed shares. 1 other person at Orchestra Biomed bought some too, in the same month.
Insider buying
Traded Dec 19, 2024 · filed 1 day later
Since the trade +51.0% · S&P 500 +28.7% · to Nov 13
The CFO of Orchestra Biomed paid $4.8K out of pocket for Orchestra Biomed shares. 1 other person at Orchestra Biomed bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Dec 18, 2024 · filed 1 day later
Since the trade +52.3% · S&P 500 +28.7% · to Nov 13
An Orchestra Biomed director paid $25K out of pocket for Orchestra Biomed shares. 1 other person at Orchestra Biomed bought some too, in the same month. It was the first purchase in over a year.
May 15, 2026~$35K · 8,971 sh @ $3.90
DetailsOfficial recordApr 29, 2025~$127K · 50K sh @ $2.53
DetailsOfficial record26 open-market purchases and 8 open-market sales by insiders of OBIO between Feb 22, 2023 and today, placed against the company's last 1 earnings release. The latest on file was filed Mar 24, 2023. The data provider lists the next release for Mar 10, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Mar 24, 2023 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies